Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,258 public trials 1,195 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer

NCT00008385

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
  • Arizona Oncology Services Foundation Phoenix, Arizona, United States
  • Virginia G. Piper Cancer Center at Scottsdale Healthcare - Osborn Scottsdale, Arizona, United States
View all 532 locations
View Trial Details
Completed

A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors

NCT05116891

Conditions
Advanced Solid Tumors, Biliary Tract Cancer, Biliary Tract Diseases, +22 more
Locations
  • EDOG Institut de Cancerologie de l'Ouest - PPDS Saint-Herblain, Boulevard Jacques Monod, France
  • Centre Georges François Leclerc Dijon, Côte-d'Or, France
  • Institut Bergonie Bordeaux, France
  • Centre Eugene Marquis Rennes, France
View Trial Details
Completed

Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours

NCT02482311

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +26 more
Locations
  • Research Site Fayetteville, Arkansas, United States
  • Research Site San Francisco, California, United States
  • Research Site West Hollywood, California, United States
  • Research Site Fort Myers, Florida, United States
View all 16 locations
View Trial Details
Completed

TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers

NCT03829436

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • University of California - San Francisco San Francisco, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer

NCT00064350

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Stanford Comprehensive Cancer Center - Stanford Stanford, California, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 141 locations
View Trial Details
Completed

Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer

NCT01824901

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Emory University Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Eastern Cooperative Oncology Group (ECOG) Research Base Brookline, Massachusetts, United States
View Trial Details
Completed

Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer

NCT00103207

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +14 more
Locations
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
  • St. Anthony Central Hospital Denver, Colorado, United States
  • Porter Adventist Hospital Denver, Colorado, United States
View all 157 locations
View Trial Details
Completed

Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC

NCT03989115

Conditions
Adnexal Diseases, Bronchial Diseases, Bronchial Neoplasms, +61 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • UC Irvine - Chao Family Comprehensive Cancer Center Orange, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
View all 24 locations
View Trial Details

Related conditions